GE HEALTHCARE TECH.INC. Cash Flow Reinvestment Rate

Latest as of March 2026: 0.66x

GE HEALTHCARE TECH.INC. cash flow reinvestment rate. GE HEALTHCARE TECH.INC. (L0T) has a Cash Flow Reinvestment Rate of 0.66x as of March 2026, reinvesting €191.00 Million (capex €178.00 Million plus investments €-13.00 Million) from operating cash flow of €290.00 Million. See L0T FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.

Reinvestment Rate

0.66x
(Capex + Investments) / Operating CF

Total Reinvested

€191.00 Million
Capex + Investments

Operating Cash Flow

€290.00 Million
EUR

Capital Expenditures

€178.00 Million
EUR

Cash Flow Reinvestment Rate of GE HEALTHCARE TECH.INC. (2022–2025)

Cash flow reinvestment rate of GE HEALTHCARE TECH.INC. from 2022 to 2025. Historical reinvestment intensity for GE HEALTHCARE TECH.INC. across 4 annual periods. Explore GE HEALTHCARE TECH.INC. (L0T) cash flow to debt to assess how comfortably operating cash covers total debt obligations.

GE HEALTHCARE TECH.INC. Cash Flow Reinvestment Rate by Year (2022–2025)

GE HEALTHCARE TECH.INC. cash flow reinvestment rate by year from 2022 to 2025. Year-by-year capital reinvestment analysis for GE HEALTHCARE TECH.INC.. For the full cash flow conversion analysis, see GE HEALTHCARE TECH.INC. cash flow conversion.

Year Reinvestment Rate Total Reinvested (EUR) Operating CF Capex YoY Change
2025 0.30x €600.00 Million €1.99 Billion €482.00 Million ▲ +33.6%
2024 0.23x €441.00 Million €1.95 Billion €401.00 Million ▲ +9.2%
2023 0.21x €435.00 Million €2.10 Billion €387.00 Million ▲ +18.6%
2022 0.17x €369.00 Million €2.11 Billion €310.00 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow